Apogee Therapeutics, Inc. (APGE) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$227.45M | -32.9% |
| 2024 | -$171.17M | -129.0% |
| 2023 | -$74.76M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$227.45M | -32.9% |
| 2024 | -$171.17M | -129.0% |
| 2023 | -$74.76M | — |